Studies have shown that miR-503-3p is overexpressed in TAM-EVs, activating the Wnt/β-catenin signaling pathway by targeting DACT2, promoting glycolysis and reducing mitochondrial oxidative phosphorylation in BC cells, thereby advancing BC development (166). This evidence concerns the gene DACT2 and breast cancer.